AurobindoPharma USA, Inc. recalls Aurobindo, Acetris — Valsartan and Amlodipine and Valsartan tablets
- Recall date
- March 1, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- AurobindoPharma USA, Inc., Aurobindo, Acetris
Why it was recalled
Due to the detection of NDEA (N-Nitrosodiethylamine) Impurity — Unapproved Ingredient
What was recalled
Valsartan and Amlodipine and Valsartan tablets
Read the official recall notice →
Get recall alerts
Free email alert whenever AurobindoPharma USA, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: AurobindoPharma USA, Inc., Aurobindo, Acetris